Bubble continuous positive airway pressure in the treatment of severe paediatric pneumonia in Malawi: a cost-effectiveness analysis.

ABSTRACT:

Objectives

Pneumonia is the largest infectious cause of death in children under 5 years globally, and limited resource settings bear an overwhelming proportion of this disease burden. Bubble continuous positive airway pressure (bCPAP), an accepted supportive therapy, is often thought of as cost-prohibitive in these settings. We hypothesise that bCPAP is a cost-effective intervention in a limited resource setting and this study aims to determine the cost-effectiveness of bCPAP, using Malawi as an example.

Design

Cost-effectiveness analysis.

Setting

District and central hospitals in Malawi.

Participants

Children aged 1 month-5 years with severe pneumonia, as defined by WHO criteria.

Interventions

Using a decision tree analysis, we compared standard of care

SUBMITTER: Kortz TB 

PROVIDER: S-EPMC5734302 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature